Share on StockTwits

Vectura Group PLC (LON:VEC)‘s stock had its “buy” rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Thursday. They currently have a GBX 192 ($3.21) price target on the stock. Canaccord Genuity’s price target would indicate a potential upside of 38.13% from the company’s current price.

A number of other analysts have also recently weighed in on VEC. Analysts at N+1 Singer reiterated a “hold” rating on shares of Vectura Group PLC in a research note on Tuesday. They now have a GBX 135 ($2.26) price target on the stock. Finally, analysts at FinnCap reiterated a “buy” rating on shares of Vectura Group PLC in a research note on Thursday, July 17th. They now have a GBX 202 ($3.38) price target on the stock. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of GBX 178 ($2.98).

Vectura Group PLC (LON:VEC) opened at 139.296 on Thursday. Vectura Group PLC has a 1-year low of GBX 94.25 and a 1-year high of GBX 171.50. The stock has a 50-day moving average of GBX 139.9 and a 200-day moving average of GBX 142.4. The company’s market cap is £557.0 million.

Vectura Group plc (LON:VEC) is a developer of therapies principally for the treatment of respiratory diseases.

Receive News & Ratings for Vectura Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vectura Group PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.